GLAUCOMA AND GLAUCOSAN DROPS
نویسندگان
چکیده
منابع مشابه
Compliance with Glaucoma Therapy with Eye Drops and its Determinants in Glaucoma Pa-tients Presenting to Clinics Affiliated to Shiraz University of Medical Sciences
Background: The present study was conducted to investigate medication compliance and its determinants in glaucoma patients presenting to Shahid Motahari Clinic affiliated to Shiraz University of Medical Sciences, Shiraz, Iran. The correlation between quality of life and the level of medication compliance was also evaluated in these patients. Materials and Methods: The present descriptive-analyt...
متن کاملGlaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
PURPOSE To determine whether chronic topical glaucoma therapy can control intraocular pressure (IOP) and protect nerve fibers in a rat model of pressure-induced optic nerve damage. METHODS Sixteen adult Brown Norway rats were-administered unilateral episcleral vein injections of hypertonic saline to produce scarring of the aqueous humor outflow pathways. Twice daily applications of either art...
متن کاملAtenolol eye drops in glaucoma: a double-masked, controlled study.
Guttae atenolol 4% (Tenormin), a pure beta1-blocking (i.e., cardioselective) drug, produced a median overall fall of 5-6 mmHg (range 3-2 to 13-2 mmHg) in the first tonometrised eyes of 7 patients with open-angle glaucoma or ocular hypertension and 1 with closed-angle glaucoma (off any treatment for the whole of the day preceding each test day) after allowance for an 'effect' of guttae saline 0-...
متن کاملSelective laser trabeculoplasty in the treatment of pseudoexfoliation glaucoma in patients allergic to all anti-glaucoma drops.
Secondary chronic open-angle glaucoma associated with pseudoexfoliation (PEX) syndrome accounts for approximately 25% of all glaucomas and represents the most common identifiable cause of glaucoma overall. Selective laser trabeculoplasty (SLT) is effective in reducing intraocular pressure (IOP) in glaucomatous patients and has the advantage of preserving surrounding structures. We report here S...
متن کاملExperimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Elevated intraocular pressure (IOP) in glaucoma causes loss of retinal ganglion cells (RGCs) and damage to the optic nerve. Although IOP is controlled pharmacologically, no treatment is available to restore retinal and optic nerve function. We evaluated the effects of NGF eye drops in a rat model of glaucoma. We also treated 3 patients with progressive visual field defects despite IOP control. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 1930
ISSN: 0007-1161
DOI: 10.1136/bjo.14.4.172